Australia's national health body lays out science-backed guidance on what and how much to eat for long-term health. The recommendations come from independent nutrition experts reviewing the best available research on food patterns that reduce disease risk.
Health & Wellness News
European food safety regulators have approved a specific type of dietary fiber that naturally triggers the body to release GLP-1, the same hunger-reducing hormone that Ozempic mimics.
Starting July 1, Medicare will cover GLP-1 obesity drugs like Wegovy, opening up access for millions of seniors who previously couldn't afford them.
A registered dietitian breaks down 19 manageable changes — think reading nutrition labels and moderating alcohol — that can meaningfully improve your diet without a full overhaul. The advice draws on CDC and FDA guidance, keeping suggestions practical for everyday life.
Researchers are working on new formulations of GLP-1 drugs that could reduce how often patients need to take them — potentially shifting from weekly injections to just once a quarter.
A psychological phenomenon called "ghost fat" is being reported among people who've lost significant weight on GLP-1 drugs — they continue to see themselves as overweight even after the pounds are gone, similar to body dysmorphia.
A large observational study found that breast cancer patients who took GLP-1 drugs had better survival outcomes compared to those who didn't. Researchers say the findings are promising but call for formal clinical trials to confirm whether the drugs are actually responsible for the benefit.
A therapist who specializes in eating disorders addresses the complicated pull that GLP-1 weight-loss drugs can have for people already struggling with their relationship with food.